Between 1 July 2021 and 1 September 2021, the following notified bodies (NBs) have been added to the lists of NBs available for operation under the Medical Device Regulation (MDR, 2017/745) and In Vitro Diagnostics Regulation (IVDR, 2017/746), according to the NANDO database: TÜV Rheinland Italia (23rd NB under the MDR) GMed SAS (6th NB…
MDCG 2021-23 is a new guidance document published by the Medical Device Coordination Group (MDCG) addressed to importers and distributors of medical devices on the requirements in Article 16 of the regulations. Article 16 is headed ‘Cases in which obligations of manufacturers apply to importers, distributors or other persons’, and apply in cases such as:…
MedTech Europe (MTE), the European trade association representing the medical technology industry including diagnostics, medical devices and digital health, has provided its response to the European Commission’s adoption consultation on the proposed Artificial Intelligence Act (AIA). The Association comments that: “Artificial Intelligence (AI) technology is increasingly used in healthcare and in recent years has been…
The US Food and Drug Administration has now published its revised user fees for its fiscal year (FY) 2022, which starts on 1 October 2021. Any submissions or applications arriving at the Agency on or after 1 October 2021 will need to have paid the new fees, which are:
The European Medicines Agency (EMA) has published a new guidance document, titled ‘Guideline on quality documentation for medicinal products when used with a medical device’, providing advice on the quality information that manufacturers of combination products should submit in marketing authorization applications (MAA) to the Agency. The guideline also incorporates the recent revision of the…
In only a trickle rather than the desired flood, the first five standards to be harmonised under the MDR and IVDR have been published in the Official Journal of the European Communities (OJEC). Four of the standards are identified for both MDR and IVDR, covering sterilization, and one has been identified for medical devices only,…
The International Medical Device Regulators Forum (IMDRF) has published guidance document WG/N66FINAL:2021, titled ‘Assessment and Decision Process for the Recognition of a Conformity Assessment Body Conducting Medical Device Regulatory Reviews’. The document explains the assessment process and outcomes, including the method to “grade and manage” nonconformities resulting from a recognizing Regulatory Authority’s assessment of a…
MDCG 2021-19, ‘Guidance note integration of the UDI within an organisation’s quality management system’, has now been published by the Medical Device Coordination Group (MDCG), detailing its advice on how, when implementing the requirements of the MDR/IVDR related to its QMS, manufacturers should consider how the UDI system and related MDR/IVDR obligations should be integrated….
The US Food and Drug Administration (FDA) has now finalized its guidance on requirements for unique device identifiers (UDI), nearly five years after releasing its draft guidance and eight years after issuing the UDI final rule. FDA said the final guidance is intended to describe “the requirements for, and FDA’s recommendations regarding, the form and…
MedTech Europe – the European trade association for the medical technology industry including diagnostics, medical devices and digital health – has provided rapid feedback on the decision by the Council of the European Union, to endorse the text of the future Regulation on Health Technology Assessment (HTA). MedTech Europe comments that: “Our industry supports EU…